Sign in

CIK 0001107421

  • Non-accelerated filer
  • Smaller reporting company

Alaunos Therapeutics, Inc.

Sign in to watch
Ticker
TCRT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
841475642
Phone
+1 346-355-4099
Business address
501 E LAS OLAS BLVD, SUITE 300, FORT LAUDERDALE, FL, 33301
Former names
ZIOPHARM ONCOLOGY INC, EASYWEB INC
  1. 4 Grant or award Director acquired 7,500 shares (grant or award)
  2. 4 Grant or award Director acquired 7,500 shares (grant or award)
  3. 4 Grant or award CEO acquired 150,000 shares (grant or award)
  4. 4 Grant or award President, COO & Treasurer acquired 50,000 shares (grant or award)
  5. 4 Open-market buy Director bought 175,000 shares at $3.10 ($542,500)
  6. 4 Open-market buy Director bought 50,000 shares at $3.10 ($155,000)
  7. 4 Open-market buy 10% owner bought 457,766 shares at an average $2.18 ($999,898)
  8. 4 Shares withheld for taxes CEO gave up 47,625 shares (to pay taxes)
  9. 4 Shares withheld for taxes President, COO & Treasurer gave up 15,875 shares (to pay taxes)
  10. 4 Grant or award Director acquired 30,000 shares (grant or award)
  11. 4 Grant or award Director acquired 30,000 shares (grant or award)
  12. 4 Grant or award Director acquired 30,000 shares (grant or award)
  13. 4 Grant or award Director acquired 30,000 shares (grant or award)
  14. 4 Grant or award CEO acquired 300,000 shares (grant or award)
  15. 4 Grant or award President, COO & Treasurer acquired 100,000 shares (grant or award)
  16. 4 Grant or award Director acquired 30,000 shares (grant or award)
  17. 4 Grant or award Director acquired 30,000 shares (grant or award)
  18. 4 Open-market buy Director bought 50,000 shares at $1.83 ($91,250)
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 19 of 24 · 465 filings